Related Experiment Video
Updated: May 11, 2026

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain
Published on: October 24, 2017
Molecular mechanism of misfolding and aggregation of Aβ(13-23)
Sándor Lovas1, Yuliang Zhang, Junping Yu
1Department of Biomedical Sciences, Creighton University, Omaha, Nebraska 68178, United States. slovas@creighton.edu
Abstract:
The misfolding and self-assembly of the amyloid-beta (Aβ) peptide into aggregates is a molecular signature of the development of Alzheimer's disease, but molecular mechanisms of the peptide aggregation remain unknown. Here, we combined Atomic Force Microscopy (AFM) and Molecular Dynamics (MD) simulations to characterize the misfolding process of an Aβ peptide. Dynamic force spectroscopy AFM analysis showed that the peptide forms stable dimers with a lifetime of ∼1 s. During MD simulations, isolated monomers gradually adopt essentially similar nonstructured conformations independent from the initial structure. However, when two monomers approach their structure changes dramatically, and the conformational space for the two monomers become restricted. The arrangement of monomers in antiparallel orientation leads to the cooperative formation of β-sheet conformation. Interactions, including hydrogen bonds, salt bridges, and weakly polar interactions of side chains stabilize the structure of the dimer. Under the applied force, the dimer, as during the AFM experiments, dissociates in a cooperative manner. Thus, misfolding of the Aβ peptide proceeds via the loss of conformational flexibility and formation of stable dimers suggesting their key role in the subsequent Aβ aggregation process.
Insights
Alzheimer
Area of Science:
- Biochemistry
- Neuroscience
- Biophysics
Background:
- Amyloid-beta (Aβ) peptide aggregation into amyloid fibrils is a hallmark of Alzheimer's disease.
- The precise molecular mechanisms driving Aβ misfolding and aggregation remain poorly understood.
Purpose of the Study:
- To investigate the initial misfolding and dimerization process of the amyloid-beta (Aβ) peptide.
- To elucidate the molecular interactions and conformational changes involved in Aβ dimer formation.
Main Methods:
- Utilized Atomic Force Microscopy (AFM) with dynamic force spectroscopy to analyze peptide-dimer interactions.
- Employed Molecular Dynamics (MD) simulations to model and characterize Aβ monomer and dimer conformations and dynamics.
Main Results:
- AFM revealed the formation of stable Aβ dimers with a characteristic lifetime of approximately 1 second.
- MD simulations demonstrated that monomers lose conformational flexibility upon approaching each other, leading to cooperative β-sheet formation in an antiparallel orientation.
- Identified stabilizing interactions including hydrogen bonds, salt bridges, and side-chain interactions within the Aβ dimer structure.
Conclusions:
- Aβ peptide misfolding initiates with the loss of conformational flexibility and the formation of stable dimers.
- These stable dimers are proposed to play a critical role in the subsequent aggregation pathway leading to Alzheimer's disease pathology.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Molecular Chaperones and Protein Folding
The...

